Loading...
Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia
BACKGROUND: The small-molecule MDM2 antagonist nutlin-3 has proved to be an effective p53 activating therapeutic compound in several preclinical cancer models, including acute myeloid leukemia (AML). We and others have previously reported a vigorous acetylation of the p53 protein by nutlin-treatment...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4032636/ https://ncbi.nlm.nih.gov/pubmed/24885082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-116 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|